Atlas Trials

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

Clinical trial NCT02856347 · COMPLETED

Trial details

NCT number
NCT02856347
Sponsor
Institut Claudius Regaud
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Medullary Thyroid Cancer
Start date
2017-03-22
Primary completion
2020-12-20
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.